Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Marc Evans, Jens Gundgaard, Brian Bekker Hansen

ABSTRACT

INTRODUCTION: To evaluate the cost-effectiveness of the co-formulation insulin degludec/insulin aspart (IDegAsp) versus biphasic insulin aspart (BIAsp 30), both administered twice daily, in patients with type 2 diabetes mellitus (T2DM), using a short-term cost-effectiveness model. METHODS: Data from two phase 3a treat-to-target clinical trials were used to populate a simple and transparent short-term cost-effectiveness model. The costs and effects of treatment with IDegAsp versus BIAsp 30 were calculated over a 5-year period, from a Danish health-care cost perspective. One-way and probabilistic sensitivity analyses were conducted to assess the degree of uncertainty and robustness of the results. RESULTS: The base-case incremental cost-effectiveness ratio (ICER) of 81,507.91 Danish Kroner (DKK) per quality-adjusted life year (QALY) demonstrates that IDegAsp is a cost-effective treatment compared with BIAsp 30, over a 5-year time horizon. One-way sensitivity analyses show that the ICERs remain within an acceptable range when the rates of hypoglycemia, unit cost of hypoglycemia, disutilities of hypoglycemic events, and the time horizon are varied, ranging from 71,012 DKK to 209,446 DKK. The probabilistic sensitivity analysis demonstrates that the probability that IDegAsp is cost-effective relative to BIAsp 30 is 99.50%, assuming a cost-effectiveness threshold of 250,000 DKK per QALY. CONCLUSION: This short-term cost-effectiveness model shows that IDegAsp is a cost-effective treatment compared with BIAsp 30 for patients with T2DM. This result is primarily driven by significant reductions in severe hypoglycemia and insulin dose observed with IDegAsp versus BIAsp 30. Sensitivity analyses demonstrate the robustness of these results. FUNDING: Novo Nordisk A/S, Søborg, Denmark. More... »

PAGES

809-823

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13300-016-0195-6

DOI

http://dx.doi.org/10.1007/s13300-016-0195-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039210731

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27553066


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cardiff and Vale University Health Board", 
          "id": "https://www.grid.ac/institutes/grid.273109.e", 
          "name": [
            "University Hospital Llandough, Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evans", 
        "givenName": "Marc", 
        "id": "sg:person.01167546340.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novo Nordisk (Denmark)", 
          "id": "https://www.grid.ac/institutes/grid.425956.9", 
          "name": [
            "Global Market Access, Novo Nordisk A/S, S\u00f8borg, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gundgaard", 
        "givenName": "Jens", 
        "id": "sg:person.0610060240.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610060240.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novo Nordisk (Denmark)", 
          "id": "https://www.grid.ac/institutes/grid.425956.9", 
          "name": [
            "Global Market Access, Novo Nordisk A/S, S\u00f8borg, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hansen", 
        "givenName": "Brian Bekker", 
        "id": "sg:person.01206630166.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206630166.68"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/dom.12250", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000463471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-014-1614-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000987540", 
          "https://doi.org/10.1007/s11095-014-1614-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-014-1614-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000987540", 
          "https://doi.org/10.1007/s11095-014-1614-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2013.852099", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002605190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/193229681000400320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002624744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/193229681000400320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002624744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dme.12261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003976834"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2013.846262", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004788363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/030079906x115757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006324797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2004.01206.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010311239"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0599-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010943073", 
          "https://doi.org/10.1007/s00125-007-0599-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0599-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010943073", 
          "https://doi.org/10.1007/s00125-007-0599-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-007-0599-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010943073", 
          "https://doi.org/10.1007/s00125-007-0599-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696990903336597", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011407413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7525-11-90", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013049175", 
          "https://doi.org/10.1186/1477-7525-11-90"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-014-3460-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015538250", 
          "https://doi.org/10.1007/s00125-014-3460-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-014-3460-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015538250", 
          "https://doi.org/10.1007/s00125-014-3460-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.910", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016435494"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2005.01501.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017098495"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2005.01501.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017098495"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/03007995.2016.1205006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018867599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/03007995.2016.1205006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018867599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2014.971160", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023138240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2012.01627.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024357147"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/dmt.14.54", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025024301"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dme.12844", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025550716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.12129", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028789451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2011.610852", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029053775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-014-0076-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029423801", 
          "https://doi.org/10.1007/s13300-014-0076-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc08-2259", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035155193"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.12032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036450839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2011.02.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037424307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1464-5491.2003.01072.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037996759"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-016-0157-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038704969", 
          "https://doi.org/10.1007/s13300-016-0157-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2012.01638.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040850913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jdiacomp.2005.08.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043376829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10198-005-0276-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043459755", 
          "https://doi.org/10.1007/s10198-005-0276-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10198-005-0276-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043459755", 
          "https://doi.org/10.1007/s10198-005-0276-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/1753-0407.12355", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043853829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2013.852098", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047381794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc13-2908", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048017302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.diabres.2014.09.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052211300"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/blr.2006.25.447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059238419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1474651410397248", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064027750"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.17.7.697", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070746398"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "INTRODUCTION: To evaluate the cost-effectiveness of the co-formulation insulin degludec/insulin aspart (IDegAsp) versus biphasic insulin aspart (BIAsp 30), both administered twice daily, in patients with type 2 diabetes mellitus (T2DM), using a short-term cost-effectiveness model.\nMETHODS: Data from two phase 3a treat-to-target clinical trials were used to populate a simple and transparent short-term cost-effectiveness model. The costs and effects of treatment with IDegAsp versus BIAsp 30 were calculated over a 5-year period, from a Danish health-care cost perspective. One-way and probabilistic sensitivity analyses were conducted to assess the degree of uncertainty and robustness of the results.\nRESULTS: The base-case incremental cost-effectiveness ratio (ICER) of 81,507.91 Danish Kroner (DKK) per quality-adjusted life year (QALY) demonstrates that IDegAsp is a cost-effective treatment compared with BIAsp 30, over a 5-year time horizon. One-way sensitivity analyses show that the ICERs remain within an acceptable range when the rates of hypoglycemia, unit cost of hypoglycemia, disutilities of hypoglycemic events, and the time horizon are varied, ranging from 71,012 DKK to 209,446 DKK. The probabilistic sensitivity analysis demonstrates that the probability that IDegAsp is cost-effective relative to BIAsp 30 is 99.50%, assuming a cost-effectiveness threshold of 250,000 DKK per QALY.\nCONCLUSION: This short-term cost-effectiveness model shows that IDegAsp is a cost-effective treatment compared with BIAsp 30 for patients with T2DM. This result is primarily driven by significant reductions in severe hypoglycemia and insulin dose observed with IDegAsp versus BIAsp 30. Sensitivity analyses demonstrate the robustness of these results.\nFUNDING: Novo Nordisk A/S, S\u00f8borg, Denmark.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s13300-016-0195-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "name": "Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective", 
    "pagination": "809-823", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "bac75541cce2bf11d6ac5161857d5e9fe03bc746f05c9edfcbb4c7e1451807be"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27553066"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101539025"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-016-0195-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039210731"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-016-0195-6", 
      "https://app.dimensions.ai/details/publication/pub.1039210731"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70037_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs13300-016-0195-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-016-0195-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-016-0195-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-016-0195-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-016-0195-6'


 

This table displays all metadata directly associated to this object as RDF triples.

204 TRIPLES      21 PREDICATES      66 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13300-016-0195-6 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N703dc5477fbe4d099ae6558aa5551319
4 schema:citation sg:pub.10.1007/s00125-007-0599-y
5 sg:pub.10.1007/s00125-014-3460-0
6 sg:pub.10.1007/s10198-005-0276-3
7 sg:pub.10.1007/s11095-014-1614-x
8 sg:pub.10.1007/s13300-014-0076-9
9 sg:pub.10.1007/s13300-016-0157-z
10 sg:pub.10.1186/1477-7525-11-90
11 https://doi.org/10.1002/hec.910
12 https://doi.org/10.1016/j.diabres.2014.09.026
13 https://doi.org/10.1016/j.jdiacomp.2005.08.005
14 https://doi.org/10.1016/j.jval.2011.02.001
15 https://doi.org/10.1046/j.1464-5491.2003.01072.x
16 https://doi.org/10.1080/03007995.2016.1205006
17 https://doi.org/10.1089/blr.2006.25.447
18 https://doi.org/10.1111/1753-0407.12355
19 https://doi.org/10.1111/dme.12261
20 https://doi.org/10.1111/dme.12844
21 https://doi.org/10.1111/dom.12032
22 https://doi.org/10.1111/dom.12129
23 https://doi.org/10.1111/dom.12250
24 https://doi.org/10.1111/j.1463-1326.2012.01627.x
25 https://doi.org/10.1111/j.1463-1326.2012.01638.x
26 https://doi.org/10.1111/j.1464-5491.2004.01206.x
27 https://doi.org/10.1111/j.1464-5491.2005.01501.x
28 https://doi.org/10.1177/1474651410397248
29 https://doi.org/10.1177/193229681000400320
30 https://doi.org/10.1185/030079906x115757
31 https://doi.org/10.2217/dmt.14.54
32 https://doi.org/10.2337/dc08-2259
33 https://doi.org/10.2337/dc13-2908
34 https://doi.org/10.2337/diacare.17.7.697
35 https://doi.org/10.3111/13696990903336597
36 https://doi.org/10.3111/13696998.2011.610852
37 https://doi.org/10.3111/13696998.2013.846262
38 https://doi.org/10.3111/13696998.2013.852098
39 https://doi.org/10.3111/13696998.2013.852099
40 https://doi.org/10.3111/13696998.2014.971160
41 schema:datePublished 2016-12
42 schema:datePublishedReg 2016-12-01
43 schema:description INTRODUCTION: To evaluate the cost-effectiveness of the co-formulation insulin degludec/insulin aspart (IDegAsp) versus biphasic insulin aspart (BIAsp 30), both administered twice daily, in patients with type 2 diabetes mellitus (T2DM), using a short-term cost-effectiveness model. METHODS: Data from two phase 3a treat-to-target clinical trials were used to populate a simple and transparent short-term cost-effectiveness model. The costs and effects of treatment with IDegAsp versus BIAsp 30 were calculated over a 5-year period, from a Danish health-care cost perspective. One-way and probabilistic sensitivity analyses were conducted to assess the degree of uncertainty and robustness of the results. RESULTS: The base-case incremental cost-effectiveness ratio (ICER) of 81,507.91 Danish Kroner (DKK) per quality-adjusted life year (QALY) demonstrates that IDegAsp is a cost-effective treatment compared with BIAsp 30, over a 5-year time horizon. One-way sensitivity analyses show that the ICERs remain within an acceptable range when the rates of hypoglycemia, unit cost of hypoglycemia, disutilities of hypoglycemic events, and the time horizon are varied, ranging from 71,012 DKK to 209,446 DKK. The probabilistic sensitivity analysis demonstrates that the probability that IDegAsp is cost-effective relative to BIAsp 30 is 99.50%, assuming a cost-effectiveness threshold of 250,000 DKK per QALY. CONCLUSION: This short-term cost-effectiveness model shows that IDegAsp is a cost-effective treatment compared with BIAsp 30 for patients with T2DM. This result is primarily driven by significant reductions in severe hypoglycemia and insulin dose observed with IDegAsp versus BIAsp 30. Sensitivity analyses demonstrate the robustness of these results. FUNDING: Novo Nordisk A/S, Søborg, Denmark.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree true
47 schema:isPartOf Na6ea7ac5efe747439d925c8c3e9c881e
48 Nff332cc7d3f04912862e7e7a947fd064
49 sg:journal.1044057
50 schema:name Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective
51 schema:pagination 809-823
52 schema:productId N0169f8f06914429eabc020aea990cb5f
53 N370810c7890d408e9b6e53fa1244c75f
54 N63b09c0cbf474654b7cb66505547fb22
55 Nc9219db6c9b2407a97bbea2c10d2daeb
56 Nd171b42147814dd699f9c57f6203bf66
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039210731
58 https://doi.org/10.1007/s13300-016-0195-6
59 schema:sdDatePublished 2019-04-11T12:37
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher Nb4c7e5c387624b65bdb9ee314a135abd
62 schema:url https://link.springer.com/10.1007%2Fs13300-016-0195-6
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N0169f8f06914429eabc020aea990cb5f schema:name dimensions_id
67 schema:value pub.1039210731
68 rdf:type schema:PropertyValue
69 N370810c7890d408e9b6e53fa1244c75f schema:name doi
70 schema:value 10.1007/s13300-016-0195-6
71 rdf:type schema:PropertyValue
72 N63b09c0cbf474654b7cb66505547fb22 schema:name nlm_unique_id
73 schema:value 101539025
74 rdf:type schema:PropertyValue
75 N703dc5477fbe4d099ae6558aa5551319 rdf:first sg:person.01167546340.80
76 rdf:rest Ndb0c8fa286a74d0e907c2461828e8521
77 Na6ea7ac5efe747439d925c8c3e9c881e schema:issueNumber 4
78 rdf:type schema:PublicationIssue
79 Nb4c7e5c387624b65bdb9ee314a135abd schema:name Springer Nature - SN SciGraph project
80 rdf:type schema:Organization
81 Nc9219db6c9b2407a97bbea2c10d2daeb schema:name pubmed_id
82 schema:value 27553066
83 rdf:type schema:PropertyValue
84 Nd171b42147814dd699f9c57f6203bf66 schema:name readcube_id
85 schema:value bac75541cce2bf11d6ac5161857d5e9fe03bc746f05c9edfcbb4c7e1451807be
86 rdf:type schema:PropertyValue
87 Ndb0c8fa286a74d0e907c2461828e8521 rdf:first sg:person.0610060240.74
88 rdf:rest Nfe912c0e6ee643c88324d5ae22654402
89 Nfe912c0e6ee643c88324d5ae22654402 rdf:first sg:person.01206630166.68
90 rdf:rest rdf:nil
91 Nff332cc7d3f04912862e7e7a947fd064 schema:volumeNumber 7
92 rdf:type schema:PublicationVolume
93 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
94 schema:name Medical and Health Sciences
95 rdf:type schema:DefinedTerm
96 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
97 schema:name Clinical Sciences
98 rdf:type schema:DefinedTerm
99 sg:journal.1044057 schema:issn 1869-6953
100 1869-6961
101 schema:name Diabetes Therapy
102 rdf:type schema:Periodical
103 sg:person.01167546340.80 schema:affiliation https://www.grid.ac/institutes/grid.273109.e
104 schema:familyName Evans
105 schema:givenName Marc
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80
107 rdf:type schema:Person
108 sg:person.01206630166.68 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
109 schema:familyName Hansen
110 schema:givenName Brian Bekker
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206630166.68
112 rdf:type schema:Person
113 sg:person.0610060240.74 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
114 schema:familyName Gundgaard
115 schema:givenName Jens
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610060240.74
117 rdf:type schema:Person
118 sg:pub.10.1007/s00125-007-0599-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1010943073
119 https://doi.org/10.1007/s00125-007-0599-y
120 rdf:type schema:CreativeWork
121 sg:pub.10.1007/s00125-014-3460-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015538250
122 https://doi.org/10.1007/s00125-014-3460-0
123 rdf:type schema:CreativeWork
124 sg:pub.10.1007/s10198-005-0276-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043459755
125 https://doi.org/10.1007/s10198-005-0276-3
126 rdf:type schema:CreativeWork
127 sg:pub.10.1007/s11095-014-1614-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1000987540
128 https://doi.org/10.1007/s11095-014-1614-x
129 rdf:type schema:CreativeWork
130 sg:pub.10.1007/s13300-014-0076-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029423801
131 https://doi.org/10.1007/s13300-014-0076-9
132 rdf:type schema:CreativeWork
133 sg:pub.10.1007/s13300-016-0157-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1038704969
134 https://doi.org/10.1007/s13300-016-0157-z
135 rdf:type schema:CreativeWork
136 sg:pub.10.1186/1477-7525-11-90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013049175
137 https://doi.org/10.1186/1477-7525-11-90
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1002/hec.910 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016435494
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1016/j.diabres.2014.09.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052211300
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1016/j.jdiacomp.2005.08.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043376829
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1016/j.jval.2011.02.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037424307
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1046/j.1464-5491.2003.01072.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037996759
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1080/03007995.2016.1205006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018867599
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1089/blr.2006.25.447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059238419
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1111/1753-0407.12355 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043853829
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1111/dme.12261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003976834
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1111/dme.12844 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025550716
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1111/dom.12032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036450839
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1111/dom.12129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028789451
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1111/dom.12250 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000463471
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1111/j.1463-1326.2012.01627.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1024357147
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1111/j.1463-1326.2012.01638.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1040850913
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1111/j.1464-5491.2004.01206.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010311239
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1111/j.1464-5491.2005.01501.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1017098495
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1177/1474651410397248 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064027750
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1177/193229681000400320 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002624744
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1185/030079906x115757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006324797
178 rdf:type schema:CreativeWork
179 https://doi.org/10.2217/dmt.14.54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025024301
180 rdf:type schema:CreativeWork
181 https://doi.org/10.2337/dc08-2259 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035155193
182 rdf:type schema:CreativeWork
183 https://doi.org/10.2337/dc13-2908 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048017302
184 rdf:type schema:CreativeWork
185 https://doi.org/10.2337/diacare.17.7.697 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070746398
186 rdf:type schema:CreativeWork
187 https://doi.org/10.3111/13696990903336597 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011407413
188 rdf:type schema:CreativeWork
189 https://doi.org/10.3111/13696998.2011.610852 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029053775
190 rdf:type schema:CreativeWork
191 https://doi.org/10.3111/13696998.2013.846262 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004788363
192 rdf:type schema:CreativeWork
193 https://doi.org/10.3111/13696998.2013.852098 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047381794
194 rdf:type schema:CreativeWork
195 https://doi.org/10.3111/13696998.2013.852099 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002605190
196 rdf:type schema:CreativeWork
197 https://doi.org/10.3111/13696998.2014.971160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023138240
198 rdf:type schema:CreativeWork
199 https://www.grid.ac/institutes/grid.273109.e schema:alternateName Cardiff and Vale University Health Board
200 schema:name University Hospital Llandough, Cardiff, UK
201 rdf:type schema:Organization
202 https://www.grid.ac/institutes/grid.425956.9 schema:alternateName Novo Nordisk (Denmark)
203 schema:name Global Market Access, Novo Nordisk A/S, Søborg, Denmark
204 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...